Comparison of hemagglutination-inhibition, complement-fixation and enzyme-linked immunosorbent assay for quantitation

Related Experiment Video

Updated: Sep 26, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

M L Martin, G W Gary, E L Palmer

    Archives of Virology
    |January 1, 1979
    PubMed

    More Related Videos

    Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus10:49

    Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

    Published on: January 28, 2019

    Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology07:04

    Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology

    Published on: January 24, 2025

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.